Where Tech Meets Bio

Where Tech Meets Bio

Share this post

Where Tech Meets Bio
Where Tech Meets Bio
Turbocharging Phenotypic Screening with AI to Target mRNA Biology
Copy link
Facebook
Email
Notes
More

Turbocharging Phenotypic Screening with AI to Target mRNA Biology

My interview with Yochi Slonim, co-founder of Israeli-based Anima Biotech, about RNA-targeting small molecule therapeutics

Andrii Buvailo's avatar
Andrii Buvailo
Mar 16, 2023
∙ Paid
3

Share this post

Where Tech Meets Bio
Where Tech Meets Bio
Turbocharging Phenotypic Screening with AI to Target mRNA Biology
Copy link
Facebook
Email
Notes
More
Share

While the pharmaceutical world is investigating biologics or mRNA-based therapies, Yochi Slonim, Israeli technology and biotech entrepreneur and public speaker on the subject of startup building and positioning, is sticking to the classics -- small molecules -- but his strategy comes with a twist.

Yochi is not a classically trained pharmaceutical scienti…

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 BiopharmaTrend (BPT Analytics Ltd)
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More